ScholarIQanswers from OpenAlex & ORCID
Giovanni Paganelli
ResearcherPublications, citations & collaboration network
Giovanni Paganelli is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Giovanni Paganelli have?
ScholarIQindexed works
Giovanni Paganelli has 552 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Giovanni Paganelli have?
ScholarIQcitation count
Giovanni Paganelli has 26,237 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Giovanni Paganelli?
ScholarIQh-index
Giovanni Paganelli has an h-index of 85 in OpenAlex.
What is the i10-index of Giovanni Paganelli?
ScholarIQi10-index
Giovanni Paganelli has an i10-index of 286 in OpenAlex.
What is the ORCID of Giovanni Paganelli?
ScholarIQorcid
The ORCID for Giovanni Paganelli is on the source record.
What is the OpenAlex record for Giovanni Paganelli?
ScholarIQopenalex
The OpenAlex for Giovanni Paganelli is on the source record.
What are the most-cited papers on Giovanni Paganelli?
ScholarIQmost cited works
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
Lisa Bodei, Mark Kidd, Giovanni Paganelli, Chiara Maria Grana, Ignat Drozdov, Marta Cremonesi, Christopher Lepensky, Dik J. Kwekkeboom, Richard P. Baum, Eric P. Krenning, Irvin M. Modlin
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, Monica Pacifici, Chiara Maria Grana, Mirco Bartolomei, Silvia M. Baio, Maddalena Sansovini, Giovanni Paganelli
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
Lisa Bodei, Marta Cremonesi, Chiara Maria Grana, Nicola Fazio, Simona Iodice, Silvia M. Baio, Mirco Bartolomei, Dario Lombardo, Mahila Ferrari, Maddalena Sansovini, Marco Chinol, Giovanni Paganelli
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Dik J. Kwekkeboom, Jan Mueller‐Brand, Giovanni Paganelli, Lowell Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maëcke, Eric P. Krenning
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study
Lisa Bodei, Marta Cremonesi, Stefania Zoboli, Chiara Maria Grana, Mirco Bartolomei, Paola Rocca, M. Caracciolo, Helmut R. Mäcke, Marco Chinol, Giovanni Paganelli